Qing Ruan

Key Laboratory Of Beam Technology Of The Ministry Of Education, P.R. China
Beijing, 100875, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

[68Ga]Ga-PG2-2FAPI: A DPro-Gly-Modified Dimeric FAPI Probe with Enhanced Tumor Uptake and Retention.

[68Ga]Ga-PG2-2FAPI: A DPro-Gly-Modified Dimeric FAPI Probe with Enhanced Tumor Uptake and Retention.

Journal: Molecular pharmaceutics

Published: February 06, 2026

Synthesis and bioevaluation of novel 99mTc-labelled ferrioxamine B isonitrile complexes as potential bacterial infection imaging agents.

Synthesis and bioevaluation of novel 99mTc-labelled ferrioxamine B isonitrile complexes as potential bacterial infection imaging agents.

Journal: European journal of medicinal chemistry

Published: October 21, 2025

Synthesis and Evaluation of Novel 99mTc-Labeled Fibroblast Activation Protein Inhibitors Containing Cyclohexane as Promising Tumor Tracers.

Synthesis and Evaluation of Novel 99mTc-Labeled Fibroblast Activation Protein Inhibitors Containing Cyclohexane as Promising Tumor Tracers.

Journal: Molecular pharmaceutics

Published: October 10, 2025

Synthesis and Biological Evaluation of a Novel 68Ga-Labeled Ubiquicidin 29-41 Complex for PET Imaging of Bacterial Infections.

Synthesis and Biological Evaluation of a Novel 68Ga-Labeled Ubiquicidin 29-41 Complex for PET Imaging of Bacterial Infections.

Journal: Molecular pharmaceutics

Published: September 25, 2025

Advances in radiolabelled CDK4/6 inhibitors for in vivo imaging of CDK4/6 activity in tumours.

Advances in radiolabelled CDK4/6 inhibitors for in vivo imaging of CDK4/6 activity in tumours.

Journal: European journal of medicinal chemistry

Published: September 12, 2025

Preparation of a Kit Formulation of [99mTc]Tc-CN7DM, a Mannose Derivative for Tumor Imaging, and an Exploratory Human Study.

Preparation of a Kit Formulation of [99mTc]Tc-CN7DM, a Mannose Derivative for Tumor Imaging, and an Exploratory Human Study.

Journal: Molecular pharmaceutics

Published: May 26, 2025

Performance evaluation of the ACTIVE 7 MAX benchtop preclinical PET scanner in accordance with the NEMA NU 4-2008 standard.

Performance evaluation of the ACTIVE 7 MAX benchtop preclinical PET scanner in accordance with the NEMA NU 4-2008 standard.

Journal: EJNMMI physics

Published: May 15, 2025

Synthesis and Preclinical Evaluation of Novel 99mTc-Labeled FR-Targeting Agents with Satisfactory Imaging Contrast and Reduced Renal Uptake.

Synthesis and Preclinical Evaluation of Novel 99mTc-Labeled FR-Targeting Agents with Satisfactory Imaging Contrast and Reduced Renal Uptake.

Journal: Journal of medicinal chemistry

Published: February 21, 2025

A novel Al18F-labelled NOTA-modified ubiquicidin 29-41 derivative as a bacterial infection PET imaging agent.

A novel Al18F-labelled NOTA-modified ubiquicidin 29-41 derivative as a bacterial infection PET imaging agent.

Journal: European journal of medicinal chemistry

Published: January 16, 2025

Development of 99mTc-Labeled Complexes with a Niraparib HYNIC Derivative for PARP-Positive Tumor Imaging.

Development of 99mTc-Labeled Complexes with a Niraparib HYNIC Derivative for PARP-Positive Tumor Imaging.

Journal: Molecular pharmaceutics

Published: January 08, 2025

Molecular engineering of melanin for enhanced biological γ-ray protection.

Molecular engineering of melanin for enhanced biological γ-ray protection.

Journal: Nature communications

Published: December 27, 2024

Current Status and Perspectives of Novel Radiopharmaceuticals with Heterologous Dual-targeted Functions: 2013-2023.

Current Status and Perspectives of Novel Radiopharmaceuticals with Heterologous Dual-targeted Functions: 2013-2023.

Journal: Journal of medicinal chemistry

Published: December 09, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026